Compare EOLS & VALU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | EOLS | VALU |
|---|---|---|
| Founded | 2012 | 1931 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 284.3M | 353.1M |
| IPO Year | 2018 | 1995 |
| Metric | EOLS | VALU |
|---|---|---|
| Price | $4.49 | $34.93 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $15.50 | N/A |
| AVG Volume (30 Days) | ★ 794.8K | 1.1K |
| Earning Date | 05-04-2026 | 03-16-2026 |
| Dividend Yield | N/A | ★ 3.64% |
| EPS Growth | 1.23 | ★ 8.91 |
| EPS | N/A | ★ 1.92 |
| Revenue | ★ $297,176,000.00 | $36,257,000.00 |
| Revenue This Year | $13.27 | N/A |
| Revenue Next Year | $17.62 | N/A |
| P/E Ratio | ★ N/A | $18.58 |
| Revenue Growth | ★ 11.61 | 1.08 |
| 52 Week Low | $3.86 | $33.51 |
| 52 Week High | $12.28 | $41.65 |
| Indicator | EOLS | VALU |
|---|---|---|
| Relative Strength Index (RSI) | 50.88 | 43.87 |
| Support Level | $4.10 | $33.51 |
| Resistance Level | $4.99 | $38.42 |
| Average True Range (ATR) | 0.19 | 0.80 |
| MACD | 0.05 | 0.02 |
| Stochastic Oscillator | 96.00 | 56.35 |
Evolus Inc is a performance beauty company offering medical aesthetic products in the cash-pay aesthetic market. The company's commercially available products represent two product categories within medical aesthetics: injectable neurotoxins and injectable hyaluronic acid (HA) gels. Its commercial products are: Jeuveau, a proprietary 900-kilodalton, purified botulinum toxin type A formulation indicated for the temporary improvement in the appearance of moderate to severe frown lines, in adults; and Evolysse, a collection of injectable HA gels that utilizes first-generation cold technology. The line includes several products, including mid face, nasolabial folds, lips, and eyes. Geographically, the company currently has operations in the United States, Canada, Europe, and Australia.
Value Line Inc is a U.S based company. It produces investment periodicals based on underlying research and making available copyright data, including ranking system and other information, to third parties under written agreements for use in third-party managed and marketed investment products and for other purposes. The company markets under brands including Value Line, the Value Line logo, The Value Line Investment Survey, Smart Research, Smarter Investing and a trusted name in Investment Research. Its only operating segment being Publishing.